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Most if not all immune functions mediated by thymus-derived (T) lympho- 
cytes appear to be associated with cell surface structures coded for by the major 
murine histocompatibility complex (MHC). 1 For example the central I-region 
of the MHC is critical for Ly 1-positive T helper cells (1-3), T cells transferring 
DTH reactions (4) and antibacterial immunity (5), and T cells proliferating in 
the MLC (6). In contrast Ly 2.3-positive  cytotoxic T lymphocytes (CTL) specific 
for alloantigens (6-9),  virus antigens (10-11), cell associated non-MHC-histo- 
compatibility antigens (12-14), and haptens (15, 16) are functionally associated 
with the peripheral H-2K or H-2D  region of the MHC.  In the case of CTL it 
has been argued that their lytic function can take place only towards H-2- 
positive  targets.  This  argument is  derived from results  showing that  both 
hapten and virus-specific H-2 restricted CTL are unable to lyse virus infected 
or hapten conjugated H-2-negative targets (17-18). 
If T cells must recognize H-2 gene products in addition to foreign antigens on 
cell  surfaces to  become sensitized  or  to  mediate lytic effector functions,  it 
should not be possible  to induce CTL with specificity for H-2-negative target 
cells.  In the experiments reported here this question has been tested using the 
H-2-negative embryonal carcinoma cell line F9 (19) as stimulator cells. 
Materials and Methods 
Mice.  CBA (H-2k), BALB/c (H-2d), and C57BL/6 (H-2  b) mice were obtained from G.I. Bomholt- 
gaard, Ry, Denmark, and 129/Sv (H-2  ~) mice from The Jackson Laboratory, Bar Harbor, Maine. 
Teratocarcinoma  Cell Lines.  The characteristics of the embryonal carcinoma cell lines used 
have been published (19, 20). Some features of the cells are summarized in Table I. The F9 cells 
* Supported by the SFB 107 (Mainz), Centre National de la Recherche Soientifique and Iustitut 
National de la Santd et de la Rdcherche  M6dicale (France). 
z Abbreviations  used  in this paper:  C, complement; Con A, concanavalin A; CTL, cytotoxic T 
lymphocytes;  DMEM,  Dulbecco's  modified  Eagle's  medium; DTH,  delayed  type  hypersensi- 
tivity;  EC,  embryo  carcinoma;  EIDso, embryo  infectivity  dose;  LPS,  lipopolysaccharide; 
MCC,  mixed  cell  cultures;  ME,  mercaptoethanol;  MHC,  m~jor  murine  histocompatibility 
complex;  MLC, mixed lymphocyte culture; PBS,  phosphate-buffered saline; R  a-MIg,  rabbit 
anti-mouse Ig; TNP, trinitrophenol. 
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TABLE  I 
Published Characteristics  of the Teratocarcinoma Cell Lines Used 
Cell types (all 
originated  Cell line designa-  In vitro differ- 
from 129 [H-  tion  entiation 
2  bc ] mice) 
Detectable antigens 
H-2  F9 
EC*  F9  0  -  + 
EC  PCC3  ++  -$  +§ 
EC  PCC4  _+  - $  + § 
Parietal  PYS-2  0  Not tested  - 
yolk  sac 
*  The data are taken from Jacob (20). 
$ Appears under conditions  of  differentiation. 
§ Disappears under conditions  of  differentiation. 
were cultivated  in tissue  culture  dishes coated with gelatin  in Dulbecco's  modified Eagle's me- 
dium  containing 15%  fetal  calf  serum  in  an  atmosphere  of  10%  CO2. The  PCC3, PCC4, and  PYS cell 
lines  do not  require  gelatine.  By subcultivating  F9, PCC3, and PCC4 cells  each 3rd  day care  was 
given  that the cells  did not grow to  confluencing monolayers. From a frozen  stock  of  cells  kept in 
liquid nitrogen each 6th wk fresh  cultures of F9 cells  were started.  Using alloimmune CTL 
generated in a primary mixed lymphocyte culture  (~e below) to test  for the presence of H-2 
antigens on the tumor cell  lines  used,  results  as given in Table II were obtained. Accordingly 
both the F9 cells  and PYS cells  were not lysed by H-2  k anti-H-2  bc immune  CTL. However 
sometimes the PCC3 and almost regularly the PCC4 cells  were lysed  significantly,  suggesting 
that some of  the cells  were H-2bC-positive,  under the conditions  used. 
Cell Cultures.  Alloantigen reactive  CTL were induced in mixed lymphocyte cultures  (MLC) 
as described (21).  In short,  spleen cells  of the various mouse strains  were used as source of 
responding and stimulating cells.  Before culture the stimulating cells  received a dose of  2,000 
rads (Philips  machine RT 200,  Philips  Electronic  Instruments, Inc.,  Mount Vernon, N. Y.) at a 
dose rate  of  620 rads/min. The cells  were cultured in multi dish culture  trays (Linbro FB-24Tc, 
Linbro Chemicals,  New  Haven, Conn.) using Dulbecco's modified Eagle's medium (DMEM) 
supplemented with 10 mM  Hepes, 5 × 10  -5 M  mercaptoethanol (ME), and 5% fetal  calf  serum. 
Splenic  responder cells  (4 × 106)  and stimulator  cells  (1.5 × 10  e)  were cultured  in  a vol  of  2 ml in 
a humidified atmosphere of 10% CO2 for 5 days.  Thereafter the cells  were collected,  washed, 
resuspended to 1 ×  106 viable cells/ml  (as determined by eosin  dye exclusion)  and tested  for 
cytotoxic  activity. 
Anti-F9 cell  immune cytotoxic  effector  cells  were induced  in mixed cell  cultures  (MCC). If  not 
stated differently responder spleen cells (4  ×  106) were cultured with 0.25  ×  106  X-irradiated 
(5,000  rads)  F9 cells in multi dish culture trays under the conditions described above. After 5 
days  the  cells  were  harvested,  their  viability  was  determined,  and  subsequently tested for 
cytotoxic activity. 
Target Cells.  In initial experiments we used as H-2-positive target cells the P815  (H-2 d) and 
EL4 (H-2 b) tumor cell lines. Because irregular results were obtained, we subsequently used only 
lipopolysaccharide (LPS) or concanavalin A  (Con A) transformed lymphoblasts as H-2-positive 
targets. Lymphoblasts were obtained by pooling replicate cultures containing 4 ×  106 spleen cells 
which had been cultured for 72  h  in  DMEM  (without ME)  containing either 5  ~g/ml  Con A 
(Pharmacia Fine Chemicals, Inc., Uppsala, Sweden) or 5 ~g/ml LPS (Difco Laboratories, Detroit, 
Mich.). The F9,  PCC3,  PCC4,  or PYS-2 cells were harvested using 1 mM EDTA in phosphate- 
buffered saline  (PBS)  (pH  7.3)  free of Mg  ++  and  Ca  ++.  The  spermatogonia were prepared as 
described below. Usually 1-2  ×  106 cells were labeled with 150 ~Ci slCr (Radio Chemical Centre, 
Amersham, England), as described (21). 
Cytotoxicity Assay.  Various numbers of viable MLC- or MCC  cells were incubated with a 
constant number (2  ×  104) 51Cr-labeled target cells. Percent specific slCr-release was calculated 
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TABLE  II 
Test for H-2  bc Alloantigens on F9, PCC3, PCC4, and PYS Cells 
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Specific lysis of 51Cr-labeled target cells* 
H'2~  H-2  d blasts  CTL  F9  PCC3  PCC4  PYS  blasts 
% 
H-T  anti-H-2t~ ~  -2  17  29  1  62  14 
H-T  anti-H-2d~  1  3  -1  0  22  75 
* Ratio attacker to target cells of 20:1, background lysis of the targets during the 4 h cytotoxicity 
assay was: F9 =  18%,  PCC3 =  24%, PCC4 =  4%, LPS induced H-2  ~  blasts =  27%, H-2  d blasts = 
22%. 
Alloimmune CTL were induced in a primary MLC. 
% specific lysis =  51Cr-release by immune cells 
-  51Cr-release by responder cells cultured without stimulater cells/maximal 51Cr-release 
-  5~Cr-release by responder cells cultured without stimulater cells ×  100. 
For  each  lymphocyte population tested  a  dose-response curve  was  established.  For  simplicity 
reasons the data are given without SD, since in the 51Cr-assays performed the SD of percent lysis 
was less than 5%. 
Antisera.  Antiserum to theta alloantigen of C3H mice (anti-Thy 1.2)  was raised as reported 
(22) and used in the complement (C)-dependent cytetexicity assay (treatment with anti-Thy 1.2 
serum and C) as described (22).  The mouse 129 anti-F9 cell hyperimmune antiserum used was a 
gift of Dr.  Rolf Kemler,  Institut Pasteur,  Paris.  Its cytotoxic titer to  F9 cells was  1:2,400,  its 
properties  have  been  described  (23).  The  H-2  k  anti-H-2  b  antiserum  was  raised  by  repeated 
intraperitoneal injections of C57BL/6 spleen cells into CBA mice. Its cytetexic titer was 1 to 128. 
Inhibition Experiments.  The "cold inhibition" assays were performed according to Herberman 
et al.  (24), the only modification being that the assay was performed in tubes instead of plastic 
dishes.  As  inhibiter  cells  LPS  induced  blast  cells  were  used.  In  the  antibody  inhibition 
experiments the target cells (2  ×  104 in 100 ~tl medium) were first incubated for 10 rain at 37°C 
with  100  pl  of antiserum  diluted  with  normal  culture  medium.  ThereaRer  the  effecter cells 
(suspended in 200 pl medium) were added. The cell mixture was centrifuged for 1 min at 200 g 
and incubated for the assay time required at 37°C in 10% CO~ and processed as described (21). 
B-CeU Removal Procedure.  Ig-positive cells within splenic lymphocytes were killed acording 
to L.  Herzenberg (personal communication) by treatment of the cells with rabbit anti-mouse Ig 
serum  (Behring-Werke AG,  Marburg Lahn W.-Germany) diluted 1:4 with PBS containing 0.2% 
Na-azide.  The cells were  washed and incubated with  agarose absorbed guinea pig serum  (22) 
containing 0.2% Na-azide to inhibit capping.  Dead cells were removed according to the method 
described by Von Boehmer and Shortman (25).  After this regimen only 2-6% of the viable cells 
were Ig positive as detected using direct immunofluorescence techniques. Viable cells were used 
as responder cells in MCC. 
Induction of Trinitrophe,ol (TNP)-Specific CTL.  The method described by Shearer (26)  has 
been used. In short, X-irradiated (3,000 rads) splenic lymphocytes (107) were incubated for 10 rain 
at  37°C  in  PBS  containing  10  mM  trinitrobenzol  sulfonic  acid  (TNBS)  (Eastman  Organic 
Chemicals Div.,  Eastman Kodak Co.,  Rochester,  N.Y.)  1  ×  10  e TNP modified mouse 129 cells 
(stimulator cells) were cocultured over 5 days together with 4  ×  10  e mouse 129 derived splenic 
responder cells.  Cytotoxic activity was tested towards LPS induced TNP-conjugated mouse 129 
derived LPS induced splenic blast cells or towards TNP-conjugated F9 cells. 
Induction  of Parainfluenza  (Sendal)  Virus-Specific  CTL.  Sendal  virus-specific  CTL  were 
obtained by injecting 104 embryo infectivity dose (EIDso)  of Sendal virus (kindly provided by Dr. 
Piinter,  Farbwerke  Hoechst AG,  Frankfurt,  W.-Germany)  into the hind footpad of mouse  129 
mice. After 5 days the draining lymph node cells were prepared and the cells were cultured for 
additional  72  h  in  vitro  (27,  28).  In  the  5~Cr-cytotoxicity,  the  target  cells  used  were  either 
syngeneic macrophages obtained as peritoneal excudate cells  (28)  or F9 cells.  The target cells 
were infected with Sendal virus (at a  multiplicity of 10 EIDso/cells for 2 h) and simultaneously 
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Preparation  of Spermatogonia.  The gonads of  4- to 6-day-old CBA and 129 mice were dissected, 
the capsules were cut with a  small scissor, and resuspended in  5 ml of PBS containing 0.1% 
trypsin.  The  organ  suspension was  incubated at  37°C and repeatedly forced through Pasteur 
pipettes to disrupt mechanically the organs. After 10-15  rain at 37°C the supernate containing 
the nonsedimenting cell content was taken, centrifuged, and the resulting cell pellet was washed 
twice. Providing the pipetting had been performed gently, about 80-90%  of the spermatogonia 
were  viable  according to  eosin  dye  exclusion criteria.  About  1-2  ×  10  e  spermatogonia were 
labeled  with  150  ~Ci  5~Cr in  a  total  vol  of  1  ml.  The  background  release  of 5~Cr labeled 
spermatogonia containing about  80%  viable  cells  was  in  the  order  of 30-40%  during  a  5  h 
incubation period. 
In Vivo Sensitization of Mice to F9 Cells.  About 2-5 ×  10  e viable F9 cells were injected s.c. In 
the  majority of mice a  palpable  tumor developed which sometimes did regress.  However the 
transplantation characteristics have not been studied in detail. The mice were used experimen- 
tally 4-6 wk after injection with F9 cells. 
Results 
Induction  of Anti-F9  Cell  Immune  CTL.  In  agreement  with  published 
work  (17,  18) we noted that  mouse 129 derived TNP-specific or Sendai virus- 
specific H°2 restricted CTL were unable to lyse TNP conjugated or Sendai virus 
infected  H-2-negative  F9  target  cells  (Table  III).  Since however F9  cells  are 
lysed when linked via lectins to CTL sensitized against any H-2 haplotype (29, 
30),  the  negative  results  might  be explained  with  the  antigen  specificity of 
antigen  primed  H-2  restricted  CTL.  Accordingly  the  inability  to  lyse  H-2- 
negative targets would not be a matter of resistance to lysis, but would merely 
reflect a  need for H-2 to trigger the recognition phase of antigen-specific CTL. 
Consequently  we tested the  possibility to  induce  anti-F9  specific  CTL.  CBA 
mice  (H-2  k) were immunized  in vivo against  F9 cells.  4 wk after priming  the 
spleen cells were used as responder cells and cocultivated in a  MCC together 
with irradiated  F9 stimulator cells. After 5 days of culture the responder cells 
were tested for cytotoxicity against 51Cr labeled F9 cells. Representative results 
obtained  are  incorporated  in  Table  III  and  clearly  suggest  that  cytotoxic 
activity  was  detectable  against  F9  targets,  irrespective  whether  they  were 
TNP  conjugated  or  Sendai  virus  infected.  It  should  be  stressed  that  the  F9 
target  cells  lysed  by  anti-F9  immune  CTL  were  not  affected  by  anti-H-2 ~ 
reactive CTL thus confirming that the F9 target cells used were H-2 negative. 
Next  we established  the  parameters  required  for the  induction  of anti-F9 
cytotoxic effector cells.  First the ratios of responder cells and  X-irradiated  F9 
stimulator cells were defined which were required to induce optimal cytotoxic 
anti-F9 responses. Using both normal and in vivo primed splenic CBA responder 
cells the highest  cytotoxic activities were induced  at  a  ratio  of about 20 to  1 
(Fig.  1).  At this  ratio  of responder cells to stimulator  cells a  4-5 day culture 
period  of  in  vivo  primed  responder  cells  yielded  higher  cytotoxic  anti-F9 
responses  compared  to  normal  responder  cells  (Fig.  2).  That  the  cytotoxic 
activity  observed  was  mediated  by  T  lymphocytes  was  suggested  by  two 
observations. First in vivo primed splenic lymphocytes enriched for T cells by 
treatment  with  R  a-MIg  and  complement  in  the  presence  of Na-azide,  and 
subsequently cultured in vitro together with F9 stimulator cells were lytic for 
F9  target  cells  (Table  IV).  Second,  treatment  of anti-F9  immune  cytotoxic 
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TABLE  III 
Lytic  Activity  of  Anti-Sendai Virus,  Anti-TNP, and Anti-F9 Cell  Immune Effeetor 
Cells 
Specific lysis of targets* 
H-2  b¢ Mac- 
H-2  b¢  rophages 
Effector  cells  H-2  bc 
F9  F9-TNP  F9 Sendai  Blasts-  Sendai vi-  Blasts  TNP  rus in- 
fected 
% 
H-2  ~  Anti-TNP  im-  0  2  ND  6  34  ND 
mune CTL$ 
H-2  t¢ Anti-Sendai virus  -1  ND  3  5  ND  27 
immune CTL$ 
H-2  k Anti-F9 cell sensi-  39  31  34  1  ND  ND 
tized effector cells 
H-2  k Anti-H-2  bc immune  2  0  3  67  ND  ND 
CTL* 
ND = not done. 
* Ratio effecter to target cells of 50:1; 6 h cytotoxicity assay; background lysis of the target cells 
was less than 34%. 
$ For details see Materials and Methods. 
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FIG.  1.  Titration of the ratio responder to stimulator cells. Spleen cells (4 x  10  e) of CBA 
primed in vivo to F9 cells (O--O--C)) or spleen cells (4  ×  106) of unprimed CBA mice 
(O- -Q- -O) were cultured with a graded number of X-irradiated (4,000 rads) F9 cells for 5 
days. The cells were harvested and assayed at a ratio of 50:1 for cytotoxicity against 51Cr- 
labeled F9 cells.  Background lysis of the F9 cells during the 5 h cytotoxicity assay was 
24%. 
activity  (Table  IV).  Representative  results  of  a  comparison  of  the  in  vitro 
responsiveness of T  cells derived from various mouse strains are summarized 
in Table  V.  Secondary  in vitro cytotoxic  anti-F9 responses could be  induced 
using CBA  (H-2k),  BALB/c  (H-2d),  C57BL/6  (H-2b),  and syngeneic mouse  129 
(H-2  ~) derived T responder cells. In contrast so far we succeeded only with CBA 
mouse derived T  responder cells to induce primary cytotoxic anti-F9 responses 
(Table V).  At present the reason for these differences is unknown. 256  T-CELL-MEDIATED  CYTOTOXICITY  TO  H'2-NEGATIVE  TARGETS 
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FIG.  2.  Kinetics of  the generation of  anti-F9 cytotoxic effector  cells.  Spleen cells  (4 x 106) 
of CBA  mice primed in vivo with F9 cells (O--O--O)  or spleen cells (4 ×  106)  of normal 
CBA  mice (0--@--0)  were cultured together with 0.25 ×  10  ~ X-irradiated F9 cells. At 
daily intervals cells were harvested and tested for cytotoxicity to 51Cr-labeled F9 target 
cells at a ratio of 50:1. Background  lysis of the target cells during the 5 h cytotoxicity 
assay was less  than 32%. 
TABLZ  IV 
Effect of Anti-Thy 1.2 Serum Plus Complement  upon Anti-F9 
Cytotoxic Effector Cells 
Treatment of anti-F9 effector 
cells generated in vitro using 
purified T cells as responder 
cells* 
Specific lysis of F9 targets 
100:15  10:1 
% 
No treatment  34  17 
Complement  38  12 
Anti-Thy 1.2 serum  36  19 
Anti-Thy 1.2 serum plus  4  -1 
complement 
* Splenic lymphocytes of CBA mice primed in vivo with F9 cells were 
treated with R a-MIg antiserum plus complement in the presence of 
Na-azide to kill Ig-positive lymphocytes. After dead cell removal the 
viable cells (4 x  106 responder cells) were cultured together with 0.25 
x  106 X-irradiated F9 stimulator cells and cultured for 5 days. 
$ Ratio effector cells to target cells. Background lysis of the target cells 
during the 5 h cytotoxicity assay was less than 16%. 
Specificity of Anti-F9 Immune  CTL.  To  explore  the  antigen  specificity of 
anti-F9 immune  CTL two approaches have been used.  First the lytic activity of 
anti-F9 immune  CTL  was tested towards  various target  cells with  known  cell 
surface antigen characteristics  (see Tables I and II). As can be seen in Table VI 
anti-F9 immune  CTL  were cytotoxic for F9,  PCC3,  and  PCC4  target  cells, yet 
did  not  lyse  syngeneic  mouse  129  targets  (H-2  positive)  nor  the  mouse  129 
parietal  yolk  sac-like PYS-2  target  cells  (F9  negative).  It  was  interesting  to 
note that  the  PYS-2 target  cells were not lysed by anti-H-2  ~  CTL,  suggesting 
that  they  may  be  devoid of H-2  antigens.  However  in  further  experiments  it WAGNER~  STARZINSKI-POWITZ~  ROLLINGHOFF~ GOLSTEIN~  AND  JAKOB 
TABLE  V 
In Vitro Cytotoxic Anti-F9 Responses of Cells Derived from 
Different Mouse Strains 
In vitro stimulation*  Specific lysis of F9 cells 
70:1§  7:1 
% 
CBAD*  ~  F9  75  19 
CBA  --* F9  42  12 
BALB/cp  ~  F9  27  4 
BALB/c  ~  F9  3  0 
C57BL/6p --* F9  24  6 
C57BL/6  --, F9  2  - 1 
129.  --* F9  19  4 
129  --* F9  0  0 
* Splenic responder cells (4 x  10  e) were cultured together with 0.25 × 
10  e X-irradiated F9 stimulator cells for 5 days. Examples of results 
obtained in independent experiments are given. 
$ p refers to splenic lymphocytes derived from mice primed in vivo to 
F9 cells. 
§ Ratio attacker cells  to target cells;  background lysis  of F9 cells  was 
less  than 28%; assay time was 5 h. 
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TABL~  VI 
Specificity of Anti-F9 lmmune CTL 
In vitro stimula-  Specific lysis of target cells$ 
H.2b¢  tion*  F9  PCC3  PCC4  PYS  H-2  d blasts 
blasts 
% 
CBAp anti-F9§  60  32  29  2  - 1  0 
CBA anti-F9  36  20  ND  4  2  3 
CBA anti-H-2  b¢  3  8  19  57  -2  12 
* Splenic responder cells (4 ×  106) were cultured together with 0.25  x  10  e X-irradiated F9 
stimulator cells  for 5 days. 
$ The data refer to a ratio of  attacker to target cells  of  50:1.  Background lysis  of  the target cells 
during the 5 h cytotoxicity assay was F9 =  24%, PCC3  =  14%, PCC4  =  27%, H-2  bc blasts = 
32%, PYS  =  11%, H-2  d blasts = 35%. 
§ Splenic CBA  cells  were derived from CBA  mice injected  s.c.  3 wk earlier  with 2 × 10  e  viable F9 
cells. 
has  to  be  firmly  established,  that  the  PYS  cells  are  not  resistant  to  CTL- 
mediated cytolysis. 
To  further  analyze  the  antigen  specificity  of  anti-F9  immune  CTL,  in  a 
second approach inhibition experiments were performed using either hyperim- 
mune  mouse  129  anti-F9  antiserum  or  unlabeled  (cold)  inhibitor  cells.  As 
shown in Table VII,  H-2  bc anti-F9 antiserum  blocked the lytic actions of H-2  k 
anti-F9 immune  CTL to  F9 target cells, yet did not effectively interfere with 
the lytic activity of alloimmune anti-H-2  bc reactive CTL. The observed blocking 
effect of mouse 129 anti-F9 antisera ruled out antibody-dependent cell cytotox- 
icity as  explanation for the  anti-F9 cytotoxicity observed,  and suggested that 
the  antiserum  used  (which  contains anti-F9 antigen antibodies  [23])  blocked 258  T-CELL-MEDIATED  CYTOTOXICITY  TO  H-2-NEGATIVE  TARGETS 
TABLE  VII 
]nhibition of Anti-F9 Cell Cytotoxicity in the Presence of Mouse 129 Anti-F9 
Antiserum 
Effector cells* 
Antisera  present  Specific lysis 
Mouse 129  H-2  k Anti-  F9 cells  H-2  ~ blasts 
Anti-F9 cell  H-2  b Anti-  70:15  7:1  50:1  5:1  antiserum  serum 
% 
H-2  k Anti-F9 cell  -  -  47  12  3  0 
immune CTL 
+ (1:20)§  -  19  2  ND 
+ (1:120)§  -  38  9  ND 
-  +  (1:20)§  44  13  ND 
H-2  k Anti-H-2  ~  -  -  6  2  67  36 
immune CTL 
-  +  (1:20)§  ND  12  3 
+ (1:20)§  -  ND  59  22 
ND = not done. 
* H-2  k anti-F9 cell immune CTL were induced by culturing  in vivo sensitized CBA spleen cells 
together with X-irradiated F9 cells for 5 days. H-2  k anti H-2  bc CTL were induced in a primary 
MLC. 
$ Ratio attacker cells to target cells; background lysis of targets was less than 37% during the 5 h 
assay time. 
§ Final dilution of anti-antiserum. 
via  competitive  inhibition  the  lytic  activity  of anti-F9  immune  CTL  to  F9 
targets.  A  corollary to these  findings was obtained  using unlabeled  (cold)  F9 
cells to block the cytolytic activity of H-2  k anti-F9 CTL to F9 targets.  Cold F9 
cells did not inhibit the lytic activity of anti H-2  ~  alloreactive CTL yet blocked 
effectively the cytotoxic activity of anti-F9 immune CTL (Table  VIII). On the 
other hand  H-2  bc blasts,  when  used  as  inhibitor  cells,  did  not  alter  the  lytic 
reactivity to F9 targets,  but to that towards H-2  ~  target cells.  Taken together 
these  results  further  supported  the  conclusion  that  H-2  antigens  are  not 
involved during the lytic effector phase of anti-F9 cell immune CTL. 
Cytolytic activity of H-2  k anti-F9 immune CTL to syngeneic spermatogonia: 
It has been reported that in adult C3H and 129 mice the F9 antigen is expressed 
on spermatozoa but not on any of the somatic cells examined (20).  In fact there 
is  evidence that,  in  contrast to somatic cells,  the  whole  male  germ line from 
primordial  germ cells  up to spermatozoa expresses  the  F9 antigen  (20).  Since 
H-2  k anti-F9 cell immune CTL were cytotoxic for all F9 antigen-positive targets 
tested  (F9,  PCC3, PCC4 cells),  and since mouse 129 anti-F9 antibodies blocked 
their  cytolytic activity,  the  possibility existed  that  anti-F9  cell  immune  CTL 
recognized the F9 antigen on F9 cells as target antigen. To further substantiate 
this  conclusion we tested  whether  H-2  k anti-F9  cell immune CTL would lyse 
~Cr-labeled spermatogonia prepared from 4-  to 6-day-old CBA (H-2  k)  and  129 
(H-2  ~)  mice. As can be seen in Table IX, H-2  k anti-F9 cell immune CTL lysed 
not  only F9  cells,  but  also  spermatogonia derived from young CBA and  129 
mice.  On the other hand H-2  d anti-H-2  k CTL did not lyse CBA mouse derived 
spermatogonia suggesting as  already  described  by others  (31)  that  the  latter 
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Effector cells 
Unlabeled inhibitor 
cells ( x  104)  Specific lysis 
H-2  bc  F9 cells  H-2  ~  Blasts 
F9 cells 
Blasts  50:1"  5:1  50:1  5:1 
% 
H-2  ~ Anti-F9S  -  -  32  9  0  -  1 
cell immune CTL 
20  -  3  0  ND 
5  -  16  3  ND 
-  20  27  8  ND 
-  5  31  10  ND 
H-2kAnti-H-2~$  -  -  4  1  87  42 
immune CTL 
20  -  ND  82  39 
-  20  ND  37  12 
ND  =  not done. 
* Ratio attacker to target cells; 2  x  104 target cells; background lysis of the targets during the 5 h 
assay was less than 33%. 
S H-2  k anti-F9 cell immune CTL were induced by culturing in vivo sensitized CBA mouse derived 
spleen cells together with X-irradiated F9 cells for 5 days. H-2  k anti-H-2  b¢ CTL were induced in 
a  primary MLC. 
TABLE  IX 
Cytolytic Activity of CBA Anti-F9 Immune CTL to CBA Mouse and 129 Mouse-Derived 
Spermatogonia 
Effector cells 
50:1" 
Specific lysis 
F9  Spermatogonia  Spermatogonia  H-2  k blasts 
(CBA)  (129) 
5:1  50:1  5:1  50:1  5:1  50:1  5:1 
CBA Anti-F9 cells  68 
immune CTL 
% 
22  44  6  11  1  2  0 
BALB/c Anti-CBAS  ND  3  1  ND  52  25 
immune CTL 
ND  =  not done. 
* Ratio effector cells to target cells; background lysis during the 5 h  cytotoxicity assay was: F9  = 
16%; CBA spermatogonia =  32%;  129 spermatogonia =  42%; H-2  k blast cells =  24%. 
S In vivo anti-F9 sensitized  CBA mouse spleen cells were  cultured for 5  days together with  X- 
irradiated  F9 cells.  BALB/c anti-CBA immune CTL were induced in a  primary MLC. 
Discussion 
The new aspect of the results  reported appears  to be the finding that  CTL 
precursors  can  be  sensitized  towards  H-2-negative  stimulator  cells  resulting 
in CTL, which in turn can recognize and lyse H-2-negative target cells. Thus 
H-2 associated CTL (8-16) and anti-F9 immune CTL differ with respect to the 
H-2 requirement for both the induction and expression of their cytolytic effector 
functions; the effector activity of anti-F9 immune CTL being H-2 independent 
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region  restricted  CTL.  The  finding  that  H-2  k  anti-F9  immune  CTL  lyse 
syngeneic spermatogonia may indicate that the effector T cells are specifically 
sensitized  towards  the  F9  antigen  (19,  20),  known  to be linked  with  the  T/t 
locus (20,  23). 
As mentioned  above so far most,  if not all,  immune  functions of murine  T 
cells  are  considered to be associated  with H.2  gene  products  (1-10,  34).  One 
possibility to explain the observed H-2 restriction of antigen primed T cells is 
to assume, that sensitization of T cells towards H-2-positive "stimulator cells" 
(which may be immunodominant)  mainly results in the activation of clonally 
restricted, H-2 associated T precursor cells. This argument implies that if non- 
H-2  restricted,  antigen-specific  CTL precursors  are  present  in  a  given T-cell 
population, their detection may be facilitated under conditions, wl~ere responder 
T  cells are sensitized to H-2-negative stimulator cells.  To test this prediction 
we used as stimulator cells embryonal carcinoma (EC) cells derived from mouse 
strain  129 (19).  The nullipotential  F9 cell line is known to be H-2 negative and 
F9  antigen  positive  (19,  20).  Similar  cell  surface  characteristics  have  been 
described for the multipotential  EC cells PCC3 or PCC4,  provided these cells 
had  been grown under  conditions  preventing  differentiation  (20).  In  contrast 
the  parietal  yolk  sac  -like  cell  line  PYS  (35)  is  known  to  be  devoid  of F9 
antigens  (20). 
The  data obtained strongly suggest that  in vivo priming  of mice with H-2- 
negative  F9 cells followed by in vitro restimulation with F9 cells triggers the 
generation of anti-F9 immune CTL.  Using this regimen anti-F9 immune CTL 
could be triggered in T cells derived from CBA (H-2k),  C57BL/6 (H-2b), BALB/c 
(H-2d),  and  129  (H-2  be) mouse stains.  In contrast  only CBA mouse derived T 
cells generated in a primary mixed cell culture cytotoxic anti-F9 cell responses. 
Since  CBA responder T  cells generated  strong  cytotoxic anti-F9  cell activity, 
such  cells  were  used  to  study  the  antigen  specificity  of the  effector  cells 
generated.  H-2  k anti-F9  cell immune  CTL lysed efficiently F9 cells,  and  to a 
lesser extent PCC3 and PCC4 cells.  The latter cells proved to be possibly H-2 
positive under the conditions used (Table VI).  However anti-F9 immune CTL 
were in no case cytotoxic for F9 antigen-negative  PYS target cells, nor for LPS 
induced  H-2  ~  blast  cells.  Moreover  mouse  129  anti-F9  antisera  effectively 
blocked the cytotoxic activity of anti-F9 cell immune  CTL against  F9 targets. 
Finally,  unlabeled  F9  cells,  but  not  H-2  ~  blast  cells  inhibited  the  cytotoxic 
reaction against F9 target cells (Tables VI and VII). Taken together these results 
strongly support the conclusion that the CTL generated recognize cell surface 
antigens present on H-2-negative F9 cells (as well as on PCC3 and PCC4 cells). 
The data also imply that in principle the lethal effect of CTL upon target cells 
can  take  place  in  the  absence  of H-2  antigens.  Thus  cytotoxic  anti-F9  cell 
responses  appear  to  represent  a  model  situation,  in  course  of  which  CTL 
precursors  are  sensitized  against  H-2-negative  cells,  resulting  in  cytotoxic 
effector T  cells capable to  recognize  and  to lyse H-2-negative target  cells.  In 
regard to the two basic models for T-cell recognition,  dual recognition or-al- 
tered self (32, 36-38) these results imply, that the lytic activity of anti-F9 cell 
immune CTL takes place in the absence of H-2 self markers. 
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have recently been obtained in other laboratories with rat  (39) and mouse (S. 
R. Burakoff, personal communication} effector cells. If one argues that anti-F9 
cytotoxic  responses  take  place  because  the  F9  cell  antigen  is  processed  by 
syngeneic macrophages during the sensitization phase, one has to explain why 
the CTL generated  are cytotoxic for H-2-negative targets  (lack of H-2 restric- 
tion).  This  argument  also  contradicts  the  remote  possibility  that  we  are 
observing CTL responses specific for FCS constituents (14). Such responses are 
H-2  restricted  (14).  Alternatively  it  is conceivable that  F9 cells do express a 
functional  analogue  to H-2  gene  products,  which  in  turn  would  enable  the 
sensitization  of CTL  in  the  absence of H-2  antigens.  This  in  turn  raises  the 
question  whether  it  is  possible to  induce  F9  cell  restricted  virus  or  hapten- 
specific CTL.  What then could be the nature  of the target  antigen  recognized 
on F9  cells? First,  out of the  limited  target  cell panel  tested only cells were 
lysed known to be F9 antigen  positive.  Second, mouse 129 anti-F9 cell antise- 
rum,  known  to  contain  antibodies  specific  for  F9  antigens  (23),  blocked the 
cytotoxic anti-F9  cell  reactivity.  Third,  spermatogonia  known  to  express  F9 
antigens  (20),  were lysed by H-2  k anti-F9 cell immune CTL. In fact, the latter 
system can be considered as an in vitro analogue of a T-cell-mediated cytotoxic 
autoimmune  orchitis  (40).  Taken  together these findings  suggest,  but do not 
prove,  that  anti-F9  cell  immune  CTL  recognize  the  F9  antigen  as  target 
antigen.  Since the F9 antigen is genetically linked to the T/t locus (19,  20, 23), 
the  possibility  has  to  be  considered  that  we  are  observing  CTL  responses 
towards gene products coded for by the T/t locus.  However recognition of EC 
antigens other than the F9 antigen has not yet been firmly excluded. 
Summary 
Murine thymus derived (T) lymphocytes primed in vivo to mouse 129 (H-2  ~) 
derived H-2-negative F9 embryonal carcinoma cells and rechallenged in vitro 
with X-irradiated  F9 stimulator cells differentiated into anti-F9 cell immune 
cytotoxic T  lymphocytes (CTL).  Using CBA mouse derived splenic responder 
T cells, F9 stimulator cells triggered a primary cytotoxic anti-F9 response. The 
CTL generated lysed the F9 antigen-positive target cells F9, PCC3, and PCC4, 
but not the F9 antigen-negative  mouse 129 derived PYS tumor cells, nor LPS 
induced H-2  ~  blast cells.  Mouse 129 anti-F9 cell antisera but not H-2  k anti-H- 
2  bc  antisera  blocked  the  lytic  interaction  with  F9  target  cells.  Similarily 
unlabeled F9 cells but not H-2  ~ blast cells inhibited the anti-F9 cell cytotoxicity. 
H-2  k  anti-F9  cell  immune  CTL  were  found  to  be  cytotoxic  for  syngeneic 
spermatogonia,  known to express the F9 antigen. 
The results suggest not only that  CTL can recognize and lyse H-2-negative 
target cells, but also that CTL precursors can be sensitized against H-2-nega- 
tive stimulator cells.  From the data available it may be inferred that anti-F9 
cell immune  CTL recognize the F9 antigen,  known to be linked with the T/t 
locus. Since anti-F9 cell immune CTL lyse syngeneic spermatogonia,  the sys- 
tem  may be useful to  analyze  in  vitro  the  induction  and  effector phase  of a 
T-cell-mediated cytotoxic autoimmune orchitis. 
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